Novartis preview - Q2 beat likely, UBS flags upside risk to 2025 guidance By Investing.com
- Posted on July 17, 2025
- By Investing.com
- 3 Views
Novartis preview - Q2 beat likely, UBS flags upside risk to 2025 guidance By Investing.com
Novartis preview - Q2 beat likely, UBS flags upside risk to 2025 guidance
